柳叶刀发布新的期刊The Lancet HIV

2014年9月初,柳叶刀The Lancet发布了新的杂志The Lancet HIV,加上去年发布的的杂志Lancet Global Health,柳叶刀期刊列表增加到了10个,从这节奏看来柳叶刀打算做期刊方阵啊。

About The Lancet HIV

About the journal

The Lancet HIV launches in autumn 2014, joining the growing collection of Lancet specialty journals. As an exclusively online journal, this new monthly title will be dedicated to publishing original research that advocates change in, or illuminates, HIV clinical practice. The journal offers the same unique Fast Track experience offered by The Lancet journals for all research papers selected for peer review, whereby articles can be published online within 8 weeks of submission.

About our content

Delivering a holistic view of the pandemic, The Lancet HIV publishes original research, comment, and correspondence that unifies clinical, epidemiological, and operational disciplines across a single vision of health for those living with HIV. The journal will cover innovative treatments and the biological research underpinning such developments, novel methods of service delivery, and new ways of confronting HIV/AIDS worldwide.

More information for authors

About the Editor

Peter Hayward was Deputy Editor of The Lancet Infectious Diseases from 2010 and helped to introduce original research and Fast Track peer review to that journal. He is the founding Editor of The Lancet HIV.
Contact: p.hayward@lancet.com

About the Editorial Advisory board

The Editorial Advisory Board will consists of key opinion leaders and researchers from around the world who lend their expertise to this journal. If you are interested in finding out more about participating as an Editorial Advisory Board Member, please emailTheLancetHIV@lancet.com.

The Lancet HIV投稿指南

The Lancet HIV is an exclusively online journal dedicated to publishing original research that advocates change in, or illuminates, HIV clinical practice. We will publish translational, epidemiological, clinical, operational, and implementation studies. All original research judged eligible for consideration by the journal’s editors will be peer-reviewed within 72 h and, if accepted, published online within 8 weeks from submission. The journal will also publish relevant commentary and correspondence. Wherever possible, figures and good quality photographs (colour or black and white) should be used to supplement and to enhance the text. We also welcome videos. Further details on the different sections of The Lancet HIV, and how to submit to the journal, are provided below. If you require further clarification, the journal's editorial staff will be pleased to help (email TheLancetHIV@lancet.com).

Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. The Lancet journals are signatories of the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations) and to the Committee on Publication Ethics (COPE) code of conduct for editors. We follow COPE's guidelines.

How to submit your paper

Statements, permissions, and signatures

Download a PDF version of the full guidelines for authors of The Lancet HIV.

The Lancet HIV投稿网址

The Lancet HIV投稿网址为ees.elsevier.com/thelancethiv/

如果有不错的稿件,可以考虑投The Lancet HIV,虽然现在还没有影响因子,但是背靠The Lancet这颗大树,相信将来影响因子会少不了。而且现在杂志刚创刊,稿件可能有限,中稿率可能会高些。

0
  • 本博客文章如未特别说明,皆为本站原创,默认采用署名-相同方式共享 4.0 国际协议
  • 相关文章

    3 thoughts on “柳叶刀发布新的期刊The Lancet HIV

      1. 科研动力 文章作者

        一般來講,新出版的雜誌因為稿源的問題,大多好發。但是The Lancet HIV因為背靠The Lancet這個大概,相對於其他期刊來說也不好發。我曾經就在the lancet global health 新發行的時候投過稿件,也沒中,呵呵。

        0
        回复

    发表评论

    电子邮件地址不会被公开。 必填项已用*标注